Industry update
Boao Lecheng says 29 frontier biomedical projects have been approved
An April 8 Hainan government report says the Boao Lecheng International Medical Tourism Pilot Zone has approved 29 frontier biomedical new-technology projects, covering areas such as stem-cell, immune-cell, and gene-therapy technologies within the zone's regulatory framework.
The Hainan Provincial People's Government website, citing Hainan Daily, reported on April 8 that Boao Lecheng had approved 29 frontier biomedical new-technology projects. The article says the approved pipeline covers fields such as stem-cell technology, immune-cell technology, and gene technology.
The same official report says the relevant indications span multiple difficult disease areas and notes that Hainan has also issued implementing rules for the translational application of biomedical new technologies inside the pilot zone. For PatientChina readers, that signals continued destination development and a structured regulatory pathway rather than a universal patient-access guarantee.
Because project approval in the pilot zone is not the same as individual eligibility, availability, or travel readiness, patients should verify directly with the relevant licensed institution what services are lawfully available, whether evaluation is required in advance, and what documentation may be needed before making travel decisions.